Inventor

GEORGANTAS III ROBERT W

US6 patents

⚠️ This page may combine multiple inventors who share the name “GEORGANTAS III ROBERT W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BIODESIX INC

2 patents

US11894147B2Feb 6, 2024

Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings

BIODESIX INC2 citations70

US11476003B2Oct 18, 2022

Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings

BIODESIX INC3 citations70

AMGEN INC

2 patents

US11016099B2May 25, 2021

Prediction of clinical response to IL23-antagonists using IL23 pathway biomarkers

AMGEN INC3 citations70

US11220541B2Jan 11, 2022

CCL20 as a predictor of clinical response to IL23-antagonists

AMGEN INC1 citations59

UNIV JOHNS HOPKINS

1 patent

US7799528B2Sep 21, 2010

Therapeutic and diagnostic applications of genes differentially expressed in lympho-hematopoietic stem cells

UNIV JOHNS HOPKINS8 citations82

MEDIMMUNE LLC

1 patent

US10006026B2Jun 26, 2018

Recombinant polypeptide production

MEDIMMUNE LLC0 citations47